EMOSIS

A start-up leading a change in in vitro diagnosis of a top tier killer and leading disabler worldwide: cardioneurovascular diseases caused or complicated by vascular thrombosis.

We develop blood tests relying on flow cytometry, a state-of-the-art powerful investigative technology. Running a prepared patient sample takes only seconds to dissect the biological intricacy of thrombosis, in a way that is out of reach of current tests.

Tests results inform lab specialists and physicians on the likelihood and stage of thrombosis to better care for patients who are facing risk of potentially lethal or disabling event.
Simply vital.